These findings support the role of AMPK suppression in promoting lipogenesis, insulin resistance, hepatic steatosis, and NAFLD (21, 81–84), highlighting the importance of AMPK/ACC signaling in metabolic regulation. The gene discussed is PRKAA1; the disease is fatty liver disease.